RB1 protein expression was assessed by IHC in tumor samples from 7,436 patients with ovarian carcinoma using TMAs from 20 centers participating in the OTTA consortium (Table 1; Supplementary Tables S1 and S10). This evidence concerns the gene RB1 and neoplasm.